Georgetown CHIR’s Katie Keith is Taking on Surprise Medical Billing
Commercial Sector Prices
Georgetown CHIR’s Katie Keith is Taking on Surprise Medical Billing
Medicare Negotiation Hearing: 3 Key Takeaways
Drug Prices
Medicare Negotiation Hearing: 3 Key Takeaways
Aduhelm Only Latest Drug to Make Case for Reform
FDA Accountability
Aduhelm Only Latest Drug to Make Case for Reform
AV Calls for Changes to Medicare Advantage to Reduce Overpayments
Medicare-Medicaid Integration
AV Calls for Changes to Medicare Advantage to Reduce Overpayments
Oasis in the Contraception Desert: Pharmacist Prescriptions Increase Access to Birth Control
Health
Oasis in the Contraception Desert: Pharmacist Prescriptions Increase Access to Birth Control
Proposed Rule from CMS Raises the Bar on Integrated Care
Medicare-Medicaid Integration
Proposed Rule from CMS Raises the Bar on Integrated Care
New Poll: Overwhelming Majority of Americans Support New Ban on Surprise Medical Billing
Commercial Sector Prices
New Poll: Overwhelming Majority of Americans Support New Ban on Surprise Medical Billing
A New Generation in the Fight for Fair Drug Prices
Drug Prices
A New Generation in the Fight for Fair Drug Prices
Massachusetts Confronts High-Priced Health System
Commercial Sector Prices
Massachusetts Confronts High-Priced Health System
4 Takeaways From a Congressional Hearing on Improving Care for People Eligible for Both Medicare and Medicaid
Medicare-Medicaid Integration
4 Takeaways From a Congressional Hearing on Improving Care for People Eligible for Both Medicare and Medicaid
Health
How Some Health Insurance Companies Are Breaking the Law
Investing in Integration: Indiana’s Long-Term Care System Redesign Focuses on Dual-Eligible Populations
Medicare-Medicaid Integration
Investing in Integration: Indiana’s Long-Term Care System Redesign Focuses on Dual-Eligible Populations
A New Way to Begin the End of HIV in the U.S.
Drug Prices
A New Way to Begin the End of HIV in the U.S.
Fallout From Controversial Alzheimer's Drug Continues
FDA Accountability
Fallout From Controversial Alzheimer’s Drug Continues
Congress: Pharma's Price Gouging is Purposeful
Drug Prices
Congress: Pharma’s Price Gouging is Purposeful
New Research Points to How to Reduce the $100 Billion Americans Spend Annually on Unnecessary Health Care
Provider Payment Incentives
New Research Points to How to Reduce the $100 Billion Americans Spend Annually on Unnecessary Health Care
Video: Health Care is Not a Functioning Market
Commercial Sector Prices
Video: Health Care is Not a Functioning Market
Medicare-Medicaid Integration
Fixing the FIDE-SNP — Redefining ‘Fully Integrated’
Medicare-Medicaid Integration
Improving Behavioral Health Supports for Dual-Eligible Individuals
Drug Pricing Reform Failure is Unacceptable
Drug Prices
Drug Pricing Reform Failure is Unacceptable
Organ Failure: The Urgent Need for Reform
Organ Donation
Organ Failure: The Urgent Need for Reform
5 Things to Watch for in the Medicare Trustees’ Report
Medicare Sustainability
5 Things to Watch for in the Medicare Trustees’ Report
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
Drug Prices
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
New Poll: Majority of Voters Want Congress To Take Action To Lower Health Care Prices
Commercial Sector Prices
New Poll: Majority of Voters Want Congress To Take Action To Lower Health Care Prices
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
- Criminal Justice
- Health
- Public Finance
- Higher Education & Career Pathways
- Infrastructure
- Evidence & Evaluation
